EGF and hepatocellular carcinoma: However, LCN2 negatively modulates epithelial–mesenchymal transition (EMT) in hepatocellular carcinoma cells through the epidermal growth factor (EGF) or transforming growth factor (TGF)-β1/LCN2/Twist1 pathway [22].